Curis Lifesciences Limited (NSE: CURIS), ISIN INE1BZN01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
CURIS last traded at ₹112.00 (+0.00%), with a 52-week range of ₹83.60 to ₹147.90 (as of 28 Jul 2026).
Shareholding as of Mar 2026: promoters 68.03%, FIIs 1.19%, DIIs 5.80%, mutual funds 0.00%.
EquiSense Score (ECS): 43/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.